{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:47Z","timestamp":1792592567558,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jtha.2024.11.019","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T12:15:37Z","timestamp":1733746537000},"page":"1085-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Disseminated intravascular coagulation and cirrhotic coagulopathy: overlap and differences. The current state of knowledge. Communication from the SSC of the ISTH"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-3623","authenticated-orcid":false,"given":"Ecaterina","family":"Scarlatescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara N.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton","family":"Lisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.11.019_bib1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib2","first-page":"265","article-title":"Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan","author":"Kobayashi","year":"1983","journal-title":"Bibl Haematol"},{"key":"10.1016\/j.jtha.2024.11.019_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A\u00a0multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria","volume":"34","author":"Gando","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3349\/ymj.2007.48.4.595","article-title":"Diagnosis of overt disseminated intravascular coagulation: a comparative study using criteria from the International Society versus the Korean Society on Thrombosis and Hemostasis","volume":"48","author":"Lee","year":"2007","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jtha.2024.11.019_bib5","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/jth.14134","article-title":"Subcommittee on Disseminated Intravascular Coagulation. A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH","volume":"16","author":"Suzuki","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.me.25.020174.002311","article-title":"Intravascular coagulation in liver disease","volume":"25","author":"Verstraete","year":"1974","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.thromres.2017.02.021","article-title":"Diagnosis of overt and non-overt disseminated intravascular coagulation: a survey among experts and a call for action from the ISTH","volume":"152","author":"Squizzato","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.11.019_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0028-1087126","article-title":"Diffuse intravascular coagulation in liver disease?","volume":"4","author":"Straub","year":"1977","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib9","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1111\/jth.14946","article-title":"Underlying disorders of disseminated intravascular coagulation: communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis","volume":"18","author":"Squizzato","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.11.019_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH08-01-0006","article-title":"Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis","volume":"99","author":"Uemura","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.11.019_bib14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jhep.2021.11.004","article-title":"Haemostatic alterations and management of haemostasis in patients with cirrhosis","volume":"76","author":"Lisman","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jtha.2024.11.019_bib15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jtha.2023.02.002","article-title":"Intraindividual variability over time of thrombin generation in patients with cirrhosis","volume":"21","author":"Sinegre","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2023.01.010","article-title":"Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation","volume":"78","author":"Zanetto","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jtha.2024.11.019_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jtha.2023.10.008","article-title":"Whole blood thrombin generation\u00a0shows a significant hypocoagulable state in patients with decompensated cirrhosis","volume":"22","author":"Zanetto","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1055\/a-1667-7293","article-title":"Prevalence of bleeding and thrombosis in critically ill patients with chronic liver disease","volume":"122","author":"Ow","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/jth.13327","article-title":"Role of hemostatic factors in hepatic injury and disease: animal models de-liver","volume":"14","author":"Kopec","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib20","first-page":"233","article-title":"Hemostasis and liver disease","volume":"66","author":"Mannucci","year":"1981","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.11.019_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0033-1334144","article-title":"Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis","volume":"39","author":"Violi","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib22","first-page":"1690","article-title":"Metabolism of fibrinogen in cirrhosis of the liver","volume":"64","author":"Tytgat","year":"1971","journal-title":"South Med J"},{"key":"10.1016\/j.jtha.2024.11.019_bib23","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2012-09-455436","article-title":"Hepatocyte tissue factor activates the coagulation cascade in mice","volume":"121","author":"Sullivan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.11.019_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2015.08.017","article-title":"Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury","volume":"64","author":"Rautou","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jtha.2024.11.019_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00281-021-00876-7","article-title":"The contact system in liver injury","volume":"43","author":"Rangaswamy","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jtha.2024.11.019_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0609.1982.tb00588.x","article-title":"Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin","volume":"29","author":"Cordova","year":"1982","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.jtha.2024.11.019_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0040-1718924","article-title":"Fibrinolysis in patients with liver disease","volume":"47","author":"von Meijenfeldt","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1975.tb00511.x","article-title":"Intravascular coagulation and the liver","volume":"30","author":"Bloom","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.11.019_bib29","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.30915","article-title":"Mixed fibrinolytic phenotypes in decompensated cirrhosis and acute-on-chronic liver failure with hypofibrinolysis in those with complications and poor survival","volume":"71","author":"Blasi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.11.019_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/gut.15.2.83","article-title":"Significance of intravascular coagulation and fibrinolysis in acute hepatic failure","volume":"15","author":"Hillenbrand","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.jtha.2024.11.019_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/gut.29.8.1103","article-title":"Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III","volume":"29","author":"Fujiwara","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.jtha.2024.11.019_bib32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1055\/s-0038-1666894","article-title":"Intravascular coagulation in autopsy cases with liver diseases","volume":"42","author":"Oka","year":"1979","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MBC.0000000000001124","article-title":"Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study","volume":"33","author":"Sivapornpan","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.11.019_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.28628","article-title":"Coagulation parameters and major bleeding in critically ill patients with cirrhosis","volume":"64","author":"Drolz","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.11.019_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MBC.0b013e32835aef6b","article-title":"Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis","volume":"24","author":"Kim","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.11.019_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2017.11.010","article-title":"The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"161","author":"Cui","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.11.019_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MAJ.0b013e31826e364d","article-title":"The significance of platelet consumption in the development of thrombocytopenia in patients with cirrhosis","volume":"346","author":"Ikura","year":"2013","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jtha.2024.11.019_bib38","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.jtha.2023.03.017","article-title":"In\u00a0vivo generation of thrombin in patients with liver disease without apparent evidence of activation of the intrinsic or extrinsic pathway of coagulation","volume":"21","author":"Elvers","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1742-6723.14058","article-title":"Prothrombinex\u00ae-VF in chronic liver disease: friend or foe?","volume":"35","author":"Latona","year":"2023","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jtha.2024.11.019_bib40","first-page":"5518","article-title":"Chronic intravascular coagulation in liver cirrhosis predicts a high hemorrhagic risk","volume":"25","author":"Ruberto","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jtha.2024.11.019_bib41","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.arth.2020.10.008","article-title":"Compensated cirrhosis is associated with increased risk of complications following total hip arthroplasty in a large Medicare database","volume":"36","author":"Sequeira","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.jtha.2024.11.019_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.arth.2020.07.019","article-title":"Impact of compensated cirrhosis etiology on postoperative outcomes following total knee arthroplasty","volume":"36","author":"Bell","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.jtha.2024.11.019_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1213\/ANE.0b013e31827ced39","article-title":"Single-dose application of antithrombin as a potential alternative anticoagulant during continuous renal replacement therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis","volume":"116","author":"Brunner","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2024.11.019_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MBC.0b013e328285d80e","article-title":"Hemostasis and global fibrinolytic capacity in chronic liver disease","volume":"18","author":"Aytac","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.11.019_bib45","first-page":"4","article-title":"Concentration of prothrombin fragment 1\u00a0+ 2 (F1\u00a0+ 2) in patients with liver cirrhosis and chronic hepatitis C infection","volume":"59","author":"Fota-Markowska","year":"2004","journal-title":"Ann Univ Mariae Curie Sklodowska Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/jhep.2003.50277","article-title":"Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis","volume":"38","author":"Colucci","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.11.019_bib47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1055\/s-0037-1615651","article-title":"Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease","volume":"85","author":"Van Thiel","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtha.2024.11.019_bib49","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1111\/j.1572-0241.1999.01446.x","article-title":"Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?","volume":"94","author":"Ben-Ari","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtha.2024.11.019_bib50","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/gut.43.3.428","article-title":"Enhanced expression of monocyte tissue factor in patients with liver cirrhosis","volume":"43","author":"Saliola","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jtha.2024.11.019_bib51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0037-1615058","article-title":"Increased thromboxane metabolites excretion in liver cirrhosis","volume":"79","author":"Dav\u00ec","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib52","first-page":"332","article-title":"Can advanced hemostatic parameters detect disseminated intravascular coagulation more accurately in patients with cirrhosis of the liver?","volume":"61","author":"Ho","year":"1998","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.jtha.2024.11.019_bib53","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s001340050472","article-title":"The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease","volume":"23","author":"Scherer","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib54","first-page":"434","article-title":"Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation","volume":"29","author":"Ferro","year":"1997","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2024.11.019_bib55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0016-5085(95)90342-9","article-title":"Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis","volume":"109","author":"Violi","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtha.2024.11.019_bib56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(95)91614-Q","article-title":"Hemostasis activation in patients with liver cirrhosis","volume":"77","author":"Vukovich","year":"1995","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.11.019_bib57","first-page":"305","article-title":"Increased concentrations of tumor necrosis factor and interleukin-6 contribute to the hemostatic abnormalities in advanced liver disease","volume":"25","author":"P\u00e1ramo","year":"1995","journal-title":"Haemostasis"},{"key":"10.1016\/j.jtha.2024.11.019_bib58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/107602969500100303","article-title":"Assessment of relative contributions of fibrinolysis and fibrinogenolysis to the abnormalities of plasma fibrinogen\/fibrin-retated D and E antigens and their ratio in liver cirrhosis","volume":"1","author":"Soon Song","year":"1995","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0049-3848(95)91463-U","article-title":"Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays","volume":"78","author":"de Maat","year":"1995","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.11.019_bib60","first-page":"230","article-title":"High D-dimer levels: a possible index of risk of overt disseminated intravascular coagulation and\/or digestive bleeding in advanced liver cirrhosis?","volume":"85","author":"Cioni","year":"1994","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib61","first-page":"83","article-title":"Fibrinopeptide-A in liver-cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver-disease","volume":"121","author":"Mombelli","year":"1993","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0268-9499(93)90056-2","article-title":"Prevalence of hyperfibrinolysis in patients with liver cirrhosis","volume":"7","author":"Ferro","year":"1993","journal-title":"Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.11.019_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/hep.1840170115","article-title":"Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation abnormalities in liver cirrhosis","volume":"17","author":"Violi","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.11.019_bib64","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0168-8278(92)90064-V","article-title":"Disseminated intravascular coagulation in liver cirrhosis","volume":"15","author":"Bakker","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jtha.2024.11.019_bib65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.2830380204","article-title":"Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices","volume":"38","author":"Koyama","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.11.019_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02919119","article-title":"Time sequence of coagulation data in patients with decompensated liver cirrhosis and suspected disseminated intravascular coagulation","volume":"21","author":"Cioni","year":"1991","journal-title":"Ric Clin Lab"},{"key":"10.1016\/j.jtha.2024.11.019_bib67","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3109\/00365529108998610","article-title":"Increased levels of fibrinolysis reaction products (D-dimer) in patients with decompensated alcoholic liver cirrhosis","volume":"26","author":"Gram","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jtha.2024.11.019_bib68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0049-3848(91)90124-F","article-title":"Coagulation activation in liver diseases","volume":"64","author":"Kemkes-Matthes","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.11.019_bib69","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00001721-199104000-00002","article-title":"Thrombin activation and increased fibrinolysis in patients with chronic liver disease","volume":"2","author":"P\u00e1ramo","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.11.019_bib70","first-page":"323","article-title":"Coagulation studies in patients with cirrhosis of liver: bleeders vs non-bleeders","volume":"33","author":"Rastogi","year":"1990","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.jtha.2024.11.019_bib71","first-page":"70","article-title":"Incidence and clinical significance of elevated fibrin(ogen) degradation product and\/or D-dimer levels in liver cirrhosis patients","volume":"22","author":"Cioni","year":"1990","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.jtha.2024.11.019_bib72","first-page":"785","article-title":"Thrombocytopenia in liver cirrhosis","volume":"52","author":"Tanaka","year":"1989","journal-title":"Nihon Ketsueki Gakkai Zasshi"},{"key":"10.1016\/j.jtha.2024.11.019_bib73","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF02774323","article-title":"Non-septic endotoxemia in cirrhotic patients","volume":"24","author":"Yajima","year":"1989","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.jtha.2024.11.019_bib74","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ajh.2830320107","article-title":"Thrombin and plasmin generation in patients with liver disease","volume":"32","author":"Takahashi","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.11.019_bib75","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/00365528809093922","article-title":"Protease inhibitors in liver disease","volume":"23","author":"Sinclair","year":"1988","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jtha.2024.11.019_bib76","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF01851203","article-title":"A\u00a0DIC-like picture on plasma and ascitic fluid of cirrhotic patients","volume":"188","author":"Patrassi","year":"1988","journal-title":"Res Exp Med (Berl)"},{"key":"10.1016\/j.jtha.2024.11.019_bib77","first-page":"126","article-title":"Fibrinopeptide A and B beta 15-42 in liver cirrhosis","volume":"18","author":"Marongiu","year":"1988","journal-title":"Haemostasis"},{"key":"10.1016\/j.jtha.2024.11.019_bib78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1620\/tjem.153.179","article-title":"Analysis of fibrinogen degradation product in severe liver disorders by immunoblotting","volume":"153","author":"Tanaka","year":"1987","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib79","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0038-1645965","article-title":"Relationship between fibrinopeptide A and fibrinogen\/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases","volume":"58","author":"Mombelli","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib80","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood.V67.5.1468.1468","article-title":"Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease","volume":"67","author":"vanDeWater","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.11.019_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.1840060115","article-title":"Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage","volume":"6","author":"Boks","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2024.11.019_bib82","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0049-3848(85)90017-9","article-title":"Alpha-antiplasmin and disseminated intravascular coagulation in liver-cirrhosis","volume":"37","author":"Marongiu","year":"1985","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.11.019_bib83","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jcp.37.5.523","article-title":"Antithrombin III metabolism in patients with liver disease","volume":"37","author":"Knot","year":"1984","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jtha.2024.11.019_bib84","first-page":"328","article-title":"Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure?","volume":"13","author":"Bertaglia","year":"1983","journal-title":"Haemostasis"},{"key":"10.1016\/j.jtha.2024.11.019_bib85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2141.1982.tb03858.x","article-title":"Antithrombin III transfusion in patients with hepatic cirrhosis","volume":"52","author":"Schipper","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.11.019_bib86","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1982.tb03920.x","article-title":"Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis","volume":"52","author":"Coccheri","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.11.019_bib87","first-page":"217","article-title":"Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis","volume":"99","author":"Stein","year":"1982","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib88","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2362.1978.tb00834.x","article-title":"Turnover of radiolabelled plasminogen and prothrombin in cirrhosis of the liver","volume":"8","author":"Collen","year":"1978","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jtha.2024.11.019_bib89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7326\/0003-4819-83-1-79","article-title":"Fibrinogen survival in cirrhosis: improvement by \u201clow dose\u201d heparin","volume":"83","author":"Coleman","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib90","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0609.1973.tb00109.x","article-title":"Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis","volume":"11","author":"van Outryve","year":"1973","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.jtha.2024.11.019_bib91","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-75-6-895","article-title":"Detection of intravascular coagulation by a serial-dilution protamine sulfate test","volume":"75","author":"Gurewich","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2024.11.019_bib92","doi-asserted-by":"crossref","first-page":"321","DOI":"10.21037\/hbsn-23-669","article-title":"Treatment of portal vein thrombosis in cirrhosis with anticoagulation\u2014more than meets the eye?","volume":"13","author":"Lisman","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jtha.2024.11.019_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145012","article-title":"Label-free kinetic studies of hemostasis-related biomarkers including D-dimer using autologous serum transfusion","volume":"10","author":"R\u00fchl","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jtha.2024.11.019_bib94","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1111\/j.1572-0241.2000.03299.x","article-title":"Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease","volume":"95","author":"Agarwal","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtha.2024.11.019_bib95","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/jth.15555","article-title":"Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis","volume":"20","author":"Bevan","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib96","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jth.12155","article-title":"Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines","volume":"11","author":"Wada","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.019_bib97","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","article-title":"How I treat disseminated intravascular coagulation","volume":"131","author":"Levi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.11.019_bib98","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2024.11.019_bib99","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/ALN.0000000000005023","article-title":"Deranged balance of hemostasis and fibrinolysis in disseminated intravascular coagulation: assessment and relevance in different clinical settings","volume":"141","author":"Scarlatescu","year":"2024","journal-title":"Anesthesiology"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:10:31Z","timestamp":1772327431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624007098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538783624007098"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.11.019","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disseminated intravascular coagulation and cirrhotic coagulopathy: overlap and differences. The current state of knowledge. Communication from the SSC of the ISTH","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}